The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Mrindia...you fail to mention that not long ago you sold a huge chunk ..was it 5m... you never did say....and then had the audacity to buy back again, despite your constant drivel...and please don't tell me to focus on Vlad, as it's not him that moans like a baby every day on here..take an example from JHFH your mentor and do one..
Bit more volume and HEMO has the potential to move now lot more fluid . Yes be positive guys not long now what's another few weeks or days who knows.
One thing is for sure: whining negativity is not going to achieve anything. Either sell-up or offer something constructive seems the obvious answer to me.
Mr I hopefully that's your thought for the week. Silence can have positive connotations too. Like, working away industriously, getting the job done and we'll announce something when it's tangible and there is something of merit to bring to our attention. I would implore you to rest on what you have said, be as patient as you can be and not let this be flavour of a daily or hourly post. News will come when it comes. GL you and all
Oh enough MrI. Filter button to the rescue again.
Dhub ... We have been saying news is incoming for the last 3 years my friend. We could have probably tripled our money in a FTSE 100 company by now which is properly run and has regular updates. We are all in too deep now and cannot even derisk until trials start and there is no guarantee trial news will make this rise again above 2p or buyers would have come by now. My personal feeling is that people need news on licencing or funding not trials (as that is already priced in and results wont be till December).
I was told many times that after a placing the shares bounces back to the placing price. This has been a long time and no rebound. Too many sellers and hardly anyone interested in buying. Trust is low in vlad and no one knows what is really happening in hemo. A Web site is nice but only makes a difference when new investors see it. Even the recent pump they tried by putting a report in daily mail had zero effect
I am now immune to anything on LSE that is written or any pumping from vlad and his rubbish RNSs. We just wait to see our money after 5 years of waiting. Good luck all we need it.
Agreed, I think JHFH is taking a break, and who can blame him. As soon as this jumps over 2p again on some serious news, I'm sure he'll be back.
Mr I, it is concerning we've had no news yet, but I'm sure it isn't that far away. I'm still positive it'll come on, or around the Results RNS. At least the website is updated, and about bloody time
Rather than worrying about individual investors of hemo, should we not be concerned there is still no news on trials, funding, licencing, prevail etc
Why do people continue to think a change in web site design will attract the new investors we need? I am not selling but sitting here and just hoping is not a strategy and I cannot understand why its been nearly 2 months and we don't have details on anything except for a website update. This really is a strangely run company
He told everyone a few weeks ago that he was done with this BB. I think he'll be back but I get why he left - too many twats on here.
JustHereForHemo has been awfully quiet recently.
And there has not been a pip from him regarding the new website, something that has long been on his wishlist.
It all leads me to think that he might have been involved in the process.
If that is the case, thanks mate, it looks good.
Pwil, it would be very disappointing if months away. Id like to think we will get an update on trial programme soon. If the aspiration is to report 3 results at the American Society of Haematology conference in early December and assuming they use November to prepare the presentation - then perhaps the third trial starts early October (and trial one and two early August and September respectively). Im hoping trials RNS July therefore if not before - although will that move the sp? a favourable milestone payment RNS surely would. Good luck with your top up
Don't panic,this new virus is called disease x....and Vlad keeps telling us CBR is there to stop disease x...
Not entirely surprising but it again highlights Hemo’s work against ‘all’ viruses.
https://www.theguardian.com/world/2024/apr/20/next-pandemic-likely-to-be-caused-by-flu-virus-scientists-warn
Unfortunately a peach of an RNS is probably months away. I hope for this peach of an rns but just can't see it being soon Unfortunately. Onwards and upwards. If it drop any further I will be having a large and final top up in May. Gla
Most probably driven by fear of potential M.E. escalation over the weekend, unlikely as that currently appears.
For FOMO Friday, there seems a hell of a lot of sells compared to buys today. Bargain price of the day has to be this one below. NOT!!!!
Was it really worth it??? How awful it would be if we had a peach of a RNS on Monday. Have a good weekend all
19-Apr-24 08:12:51 1.587 750,000 Sell* 1.642 1.67 11.90k
HEMOTRUTH'You should have purchased SUPERDRY 😆
Boy it’s felt a long 10 weeks too….
Website sorted, so you might be onto something.
When the news breaks, new potential investors will see a nice updated website.
That can only be a good thing.
It been 10 weeks since the FDA gave approval for clinical trials.
Surely we will hear soon from the company as to when these are about to actually commence.
Hilver maybe the "I won" tweet by VS a few months ago was in relation to his wish to notvwanting a spin off Bait Technology strategy.. Prevail were in the presentation room when this was first brought to our attention and they were particularly vocal at the end. They've been conspicuously silent since as you rightly observe. Let's not complicate things Hemogenyx, just prove CAR T working in P1, get some JV money in for ALL of Hemo's pipeline (the website now sets them out) and use it to advance CBR in parallel. Yes EOY Report awaited eagerly. GLA
Chris, that's very interesting and I hope you are right. There has been a notable absence of Prevail either in the CH lift RNS nor any of the interviews or other media reports published since. Neither did Prevail issued anything of a congratulatory nature to promote Hemo on the CH lift on their media outlets.
Maybe Hemo board didn't like the way things seem to have gone over at BriaCell Therapeutics since Prevail's invested $4m as lead investor in its funding round. The subsequent spin out of one third of that company's pre-clinical assets, which was proposed prior to the funding round but only approved after, to a new company BriaPro, has seen BriaCell Therapeutics' share price drop from $6 at the time of the funding round (May 23), $7 just prior to the spin-out (Aug 23) down to around $2.15 (today); though the investors would seem to have received shares in BriaPro - but that's an unlisted reporting issuer in Canada.
Awaiting the Annual Report with interest.
Nothing in there that we didn't get up to in Mr Jenkins' Yr 5 science class ;)
The bait terminology is applied to the antiviral solutions CBR - chimeric bait receptor which appears to be the direct manipulation of macrophages to express viral entry protein ie what virus binds to to gain entry into the cell - thereby giving macrophages the ability to directly bind and destroy the virus while processing and informing other immune cells. BME bait macrophage engager appears to be a macrophage engaging protein attached to the bait viral entry protein - so instead of directly engineering the macrophage it is one step removed - virus binds bait then macrophage binding arm binds macrophage receptor. CMR - looks like directly engineering macrophages to express an ScFv (engineered binding domain of an antibody) which is raised to bind a specific tumour antigen. AME is one step removed ie a protein with an ScFV binding domain on one side and a macrophage engager on the other (or mRNA which is the template or set of instructions for the cells to make the protein themselves). - see diagram https://hemogenyx.com/technology/ although I am not sure if the headers for this diagram are mixed up re biologic and cell based therapies